维普期刊资源整合服务平台（V6.5）

75篇 您的检索式：作者名="Kulasingam"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	FDG-PET for management of cervical and ovarian cancer显示文摘	Havrilesky LJ Kulasingam SL Matchar DB	2005	Gynecol Oncol2005，97，1：	1
2	Activatedleukocyte cell adhesion molecule:a novel biomarker for breastcancer显示文摘	Kulasingam V Zheng Y Soosaipillai A	2009	Int J Cancer2009，125，1：	1
3	Evaluation of human papillomavirus testing in primary screening for cervical abnormalities : comparison of sensitivity, specificity, and frequency of referral 显示文摘	Kulasingam SL Hughes JP Kiviat NB	2002	JAMA2002，288，14：	1
4	Mining the ovarian cancer ascites proteome for potential ovarin cancer biomarkers显示文摘	Kuk C Kulasingam V Gunawardana C	2009	Mol Cell Proteomics2009，8，4：	1
5	Strategies for discovering novel cancer biomarkers through utilization of emerging technologies显示文摘	Kulasingam V Diamandis EP	2008	Nat Clin Pract Oncol2008，5，：	1
6	Fascin-1 is a novel biomarker of ag- gressiveness in some carcinomas显示文摘	Kulasingam V Diamandis E P	2013	BMC Med2013，11，：	1
7	Strategies for discovering novel cancer biomarkers through utilization of emering technologies显示文摘	Kulasingam V Diamandis E	2008	Nat Clin Pract Oncol2008，5，10：	1
8	Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion triage study (ALTS)显示文摘	Kulasingam SL Kim JJ Lawrence WF	2001	J Natl Cancer lnst2001，98，2：	1
9	Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral 显示文摘	Kulasingam SL Hughes JP Kiviat NB	2002	JAMA2002，288，14：	1
10	Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study(ALTS)显示文摘	Kulasingam SL Kim JJ Lawrence WF		0，，：	1
11	Surveillance after treatment for cervical intraepithelial neoplasia: outcomes,costs,and cost- effectiveness显示文摘	Melnikow J Kulasingam S Slee C	2010	Obstet Gynecol2010，116，5：	1
12	Integrating high-throughput technologies in the quest for effective bi- omarkers for ovarian cancer显示文摘	Kulasingam V Pavlou MP Diamandis EP	2010	Nat Rev Cancer2010，10，5：	1
13	Activated leukocyte cell adhesion molecule: A novel biomarker for breast cancer 显示文摘	Kulasingam V Zheng Y SoosaipiUai A	2009	Int J Cancer2009，125，1：	1
14	Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a costeffectiveness analysis 显示文摘	Kulasingam SL Rajan R St Pierre Y	2009	BMC Med2009，9，7：	1
15	Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer显示文摘	Kulasingam V Paviou MP Diamandis EP		Nature Reviews Cancer0，，：	1
16	Proteomics analysis of conditioned media from three breast cancer cell lines:a mine for biomarkers and therapeutic targets显示文摘	Kulasingam V Diamandis EP	2007	Mol Cell Proteomics2007，6，：	1
17	PDG- PET for management of cervical and ovarian cancer显示文摘	HAVRILESKY L J KULASINGAM S L MATCHAR D B	2005	Gynecol OncoI2005，97，1：	1
18	FDG-PET for management of cervical and ovarian cancer显示文摘	Kulasingam SL Matchar DB	2005	Gynecolvoncol2005，97，1：	1
19	Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma:a cost effectiveness analysis显示文摘	JeweU EL Kulasingam S Myers ER	2007	Gynecol Oncol2007，107，3：	1
20	Tissue culture-based breast cancer biomarker discovery platform显示文摘	Kulasingam V Diamandis EP	2008	Int J Cancer2008，123，：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示